Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation. The safety of abelacimab as compared with a direct oral anticoagulant in ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.